脳の半分は機能しているが,半分は機能していない.

Same author

Combined family-based association and linkage analyses in families affected by attention-deficit hyperactivity disorder.

Human genetics·2026

Same author

Global Child Neurology Capacity Building Through the Child Neurology Society International Affairs Committee: From Needs Assessment to SMART Action Goals.

Journal of child neurology·2026

Same author

AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial.

The New England journal of medicine·2026

Same author

Parental Adjustment to Child Neurofibromatosis 1: The Role of Long-Term Uncertainty.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners·2025

Same author

Methodological challenges in outcomes research for early-trials for implementation of new therapies in neuropediatric rare diseases.

Orphanet journal of rare diseases·2025

Same author

Diffusion tensor imaging in Chediak Higashi Disease.

medRxiv : the preprint server for health sciences·2025

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

関連する実験動画

脳の半分は機能しているが,半分は機能していない.

関連する概念動画

Combined family-based association and linkage analyses in families affected by attention-deficit hyperactivity disorder.

Global Child Neurology Capacity Building Through the Child Neurology Society International Affairs Committee: From Needs Assessment to SMART Action Goals.

AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial.

Parental Adjustment to Child Neurofibromatosis 1: The Role of Long-Term Uncertainty.

Methodological challenges in outcomes research for early-trials for implementation of new therapies in neuropediatric rare diseases.

Diffusion tensor imaging in Chediak Higashi Disease.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

脳の半分は機能しているが,半分は機能していない.

関連する概念動画

関連記事

Combined family-based association and linkage analyses in families affected by attention-deficit hyperactivity disorder.

Global Child Neurology Capacity Building Through the Child Neurology Society International Affairs Committee: From Needs Assessment to SMART Action Goals.

AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial.

Parental Adjustment to Child Neurofibromatosis 1: The Role of Long-Term Uncertainty.

Methodological challenges in outcomes research for early-trials for implementation of new therapies in neuropediatric rare diseases.

Diffusion tensor imaging in Chediak Higashi Disease.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.